JP Stock MarketDetailed Quotes

2160 GNI Group

Watchlist
  • 3425
  • 00.00%
20min DelayMarket to Open Dec 3 15:30 JST
171.68BMarket Cap20.69P/E (Static)

About GNI Group Company

GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.

Company Profile

Symbol2160
Company NameGNI Group
Founded2001-11-20
MarketTSE Growth
Employees840
Fiscal Year Ends12-31
AddressShinjuku Park Tower 3-7-1 Nishi-Shinjuku
Zip Code103-0023
Phone03-6214-3600
Websitewww.gnipharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Ying Luo, PhD
  • Director, Representative Executive Officer, President and Chief Executive Officer
  • --
  • Sekitani Kazuki
  • Director, Executive Officer and Chief Operating Officer
  • --
  • Toshiya Kitagawa
  • Director, Executive Officer and Chief Financial Officer
  • --
  • Ryosuke Matsui
  • Director
  • --
  • Thomas Eastling
  • Director
  • --
  • Hideaki Sashiwa
  • Independent Director
  • --
  • Kikuchi Kanako
  • Independent Director
  • --
  • Zhang Ping
  • Independent Director
  • --
Top JP Stock Gainers
Symbol Latest Price % Chg
Informetis Co.,Ltd.
281A
1080 0.00%
TMH Inc.
280A
1500 0.00%
Terra Drone
278A
2425 0.00%
Globe-ing
277A
6370 0.00%
CCReB Advisors
276A
1185 0.00%

See the daily top gainer.